DEMANC Stock Overview
Operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.338.90 |
| 52 Week High | kr.368.00 |
| 52 Week Low | kr.259.25 |
| Beta | 0.91 |
| 1 Month Change | 7.42% |
| 3 Month Change | n/a |
| 1 Year Change | 22.50% |
| 3 Year Change | 9.31% |
| 5 Year Change | 64.51% |
| Change since IPO | 224.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEMANC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 8.2% | 0.4% | 0.5% |
| 1Y | 22.5% | -9.7% | 6.3% |
Return vs Industry: DEMANC exceeded the UK Medical Equipment industry which returned -9.7% over the past year.
Return vs Market: DEMANC exceeded the UK Market which returned 6.3% over the past year.
Price Volatility
| DEMANC volatility | |
|---|---|
| DEMANC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: DEMANC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DEMANC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 21,623 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
| DEMANC fundamental statistics | |
|---|---|
| Market cap | kr.72.93b |
| Earnings (TTM) | kr.2.55b |
| Revenue (TTM) | kr.22.44b |
28.6x
P/E Ratio3.2x
P/S RatioIs DEMANC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMANC income statement (TTM) | |
|---|---|
| Revenue | kr.22.44b |
| Cost of Revenue | kr.5.90b |
| Gross Profit | kr.16.54b |
| Other Expenses | kr.13.99b |
| Earnings | kr.2.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 11.72 |
| Gross Margin | 73.72% |
| Net Profit Margin | 11.37% |
| Debt/Equity Ratio | 126.0% |
How did DEMANC perform over the long term?
See historical performance and comparison